SITAGLIPTIN for Ill-defined disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where SITAGLIPTIN was used for Ill-defined disorder.
Most Reported Side Effects for SITAGLIPTIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Blood glucose increased | 1,427 | 7.2% | 40 | 241 |
| Pancreatic carcinoma | 1,142 | 5.7% | 725 | 361 |
| Product dose omission issue | 1,125 | 5.7% | 1 | 88 |
| Drug ineffective | 1,057 | 5.3% | 69 | 202 |
| No adverse event | 994 | 5.0% | 0 | 4 |
| Nausea | 936 | 4.7% | 81 | 484 |
| Pancreatitis | 922 | 4.6% | 177 | 507 |
| Diabetes mellitus inadequate control | 744 | 3.7% | 110 | 260 |
| Diarrhoea | 712 | 3.6% | 83 | 224 |
| Hypoglycaemia | 674 | 3.4% | 109 | 447 |
| Death | 654 | 3.3% | 653 | 241 |
| Headache | 620 | 3.1% | 57 | 242 |
| Acute kidney injury | 589 | 3.0% | 141 | 456 |
| Fatigue | 573 | 2.9% | 49 | 306 |
| Vomiting | 564 | 2.8% | 70 | 354 |
Other Indications for SITAGLIPTIN
Type 2 diabetes mellitus (6,353)
Diabetes mellitus (4,792)
Product used for unknown indication (2,161)
Blood glucose increased (126)
Blood glucose abnormal (114)
Diabetes mellitus management (86)
Blood glucose (81)
Insulin-requiring type 2 diabetes mellitus (57)
Type 1 diabetes mellitus (47)
Glycosylated haemoglobin increased (41)
Other Drugs Used for Ill-defined disorder
IBUPROFEN (707)
ATORVASTATIN (570)
DAPAGLIFLOZIN (556)
SERTRALINE (437)
AMLODIPINE (415)
ROSUVASTATIN (361)
OMEPRAZOLE (272)
DOXYCYCLINE (254)
PREGABALIN (248)
LANSOPRAZOLE (227)